Skip to main content
. 2009 Apr 21;100(10):1540–1548. doi: 10.1038/sj.bjc.6605047

Figure 2.

Figure 2

Tumour-associated trypsin inhibitor (TATI) best score for fraction of immunoreactivity in primary tumour tissue from patients with colorectal cancer and its relation to tumour (T) (A), disease (B) and to lymph node (N) stages (C). Boxes indicate mean (small central box) and mean ±1 s.e. (larger box). Whiskers indicate mean ±1.96 times s.e. Kruskal–Wallis test was used for comparison.